Q'Apel Medical Inc.

Q'Apel Medical Inc. is a neurovascular medical device manufacturer based in Fremont, California, specializing in innovative neurological catheters and access systems for stroke intervention and cerebral aneurysm treatment. Founded in 2015, the company designs advanced catheter technologies that enable therapeutic thrombectomy and neurovascular procedures with enhanced precision and patient outcomes. Q'Apel's product portfolio includes the Walrus Balloon Guide Catheter system, recognized as a leading variable-stiffness device for mechanical thrombectomy in the U.S. market; the Wahoo Control™ and Armadillo SelectFlex™ Neurovascular Access Systems, engineered for superior navigation and variable stiffness performance; and the recently FDA-cleared Zebra Neurovascular Access System. The company's devices are deployed across over 130 U.S. hospital systems and have treated more than 20,000 patients since 2019. Q'Apel is actively pursuing international expansion and continued innovation in endovascular access technology.